Clinical Trials Browser

Phase 2/3 × Not yet recruiting × Tumor-Agnostic × Clear all

NCT07476443 2026-03-17

VitC-CoQ10

Phase 2/3 Not yet recruiting

Neoplasms

NCT06337695 2024-04-02

VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer

Phase 2/3 Not yet recruiting

Neoplasm Metastasis, Neoplasms

NCT05144100 2021-12-03

SCOPE

Phase 2/3 Not yet recruiting

Carcinoma